Table 2.
Patients' model for end-stage liver disease and Child-Pugh scores
| HIFU (n = 10) | TACE (n = 29) | |
| MELD score (P = 0.687) | ||
| 14 | 0 | 2 |
| 13 | 1 | 4 |
| 12 | 1 | 4 |
| 11 | 4 | 7 |
| 10 | 1 | 3 |
| 9 | 1 | 3 |
| 8 | 0 | 1 |
| 7 | 1 | 4 |
| 6 | 1 | 1 |
| Child-Pugh score (P = 0.096) | ||
| 5 | 0 | 10 |
| 6 | 3 | 7 |
| 7 | 5 | 4 |
| 8 | 1 | 5 |
| 9 | 0 | 2 |
| 10 | 1 | 1 |
MELD: Model for end-stage liver disease; HIFU: High-intensity focused ultrasound; TACE: Transarterial chemoembolization.